The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01295021

Acronym

SORT

Enrollment

1514

Registered

2011-02-14

Start date

2011-02-28

Completion date

2012-02-29

Last updated

2013-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Keywords

The prevalence of sympathetic overactivity in hypertensive patients.

Brief summary

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

Detailed description

MC MD

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Newly diagnosed essential hypertension patients will be eligible for the study. * Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg

Exclusion criteria

* History of coronary artery disease * History of diabetes

Design outcomes

Primary

Measure	Time frame
Prevalence of SO in newly diagnosed hypertensive patients	Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion.

Secondary

Measure	Time frame
Association of SO and heart rate.	Visits 1-3
Subjective symptoms noticed by the doctor.	1st visit
To record the drugs used in the treatment of patients diagnosed with hypertension.	Visits 1-3

Countries

India

Outcome results